ATP-sensitive potassium channels are involved in adenosine-included reduction of blood pressure variability in spontaneously hypertensive rats

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 1, 2004, Pages 87-92

  Shen, Fu Ming ^a   Zhu, Guo Ming ^a   Miao, Chao Yu ^a   Guan, Yun Feng ^a   Su, Ding Feng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenosine; Adenosine receptors; ATP sensitive potassium channels; Blood pressure variability; Hypertension

Indexed keywords

6 N CYCLOPENTYLADENOSINE; ADENOSINE; ADENOSINE 5' (N CYCLOPROPYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR AGONIST; ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; PINACIDIL; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INFUSION; DRUG MECHANISM; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ADENOSINE; ANIMALS; BLOOD PRESSURE; MALE; MUSCLE, SMOOTH, VASCULAR; PINACIDIL; POTASSIUM CHANNELS; RATS; RATS, INBRED SHR; RECEPTORS, PURINERGIC P1;

EID: 3042784241     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200407000-00012     Document Type: Article

References (30)

1. Mancia G, Ferrari A, Gregorini L, et al. Blood pressure and heart rate variabilities in normotensive and hypertensive human being. Circ Res. 1983;53:96-104.
2. Su DF, Cerutti C, Barres C, et al. Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am J Physiol. 1986;251: H1111-H1117.
3. Miao CY, Shen FM, Su DF. Blood pressure variability is increased in genetic hypertension and L-NAME-induced hypertension. Acta Pharmacol Sin. 2001;22:137-140.
4. Su DF, Miao CY. Blood pressure variability and organ damage. Clin Exp Pharmacol Physiol. 2001;28:709-715.
5. Parati G, Pomidossi G, Albini F, et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertension. J Hypertens. 1987;5:93-98.
6. Mancia G, Frattola A, Parati G, et al. Blood pressure variability and organ damage. J Cardiovasc Pharmacol. 1994;24(Suppl A):6-11.
7. Jacob HJ, Alper RH, Brody MJ. Lability of arterial pressure after baroreceptor denervation is not pressure dependent. Hypertension. 1989;14:501-510.
8. 2A-receptor. J Cardiovasc Pharmacol. 2000;36:681-686.
9. Hori M, Kitakaze M. Adenosine, the heart, and coronary circulation. Hypertension. 1991;18:565-574.
10. Fredholm BB, Ijzerman AP, Jacobson KA, et al. Adenosine receptor. In: Godfraind T, Vanhouette PM, Ruffolo RR, et al. The IUPHAR Compendium of Receptor Characterization and Classification. London: IUPHAR Media; 1998:49-57.
11. 1 adenosine receptors potently regulate heart rate in mammalian embryos. Am J Physiol. 1997;273: R1374-R1380.
12. 6-cyclopentyladenosine and 8- cyclopentyltheophylline. Br J Pharmacol. 1995;115:1253-1259.
13. Shryock JC, Belardinelli L. Adenosine and adenosine receptors in the cardiovascular system: Biochemistry, physiology, and pharmacology. Am J Cardiol. 1997;79:2-10.
14. Mubagwa K, Mullane K, Flameng W. Role of adenosine in the heart and circulation. Cardiovasc Res. 1996;32:797-813.
15. 2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther. 1989;251:47-55.
16. 2 receptor in the spontaneously hypertensive rat. Am J Hypertens. 1995;8(5pt1):509-515.
17. 2 receptor-mediated vasodepression in rats: potential role for KATP channels. Fundam Clin Pharmacol. 1998;12:143-151.
18. 2a receptor. Nature. 1997;388:674-678.
19. Suzuki M, Sasaki N, Miki T, et al. Role of sarcolemmal KATP in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest. 2002;109:509-516.
20. ATP channels in rabbits. Am J Physiol Heart Circ Physiol. 2002;283:H1263-H1269.
21. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly-rectifying potassium channels in smooth muscle. Physiol Rev. 1997;77:1165-1232.
22. + channels-pharmacologic properties, regulation, and therapeutic potential. Drug Dev Res. 1993;28:95-127.
23. Bryan PT, Marshall JM. Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia. J Physiol. 1999;514:163-175.
24. Kleppisch T, Nelson MT. Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci. 1995;92:12441-12445.
25. Chen CW, Chang HY, Hsiue TR. Mechanism of adenosine-induced vasodilation in rat diaphragm microcirculation. Am J Physiol Heart Circ Physiol. 2000;279:H2210-H2217.
26. Friedel HA, Brogden RN. Pinacidil: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension. Drugs. 1990;39:929-967.
27. Sakai K, Saito K. Nicorandil, its denitrated metabolite, SG-86 and naturally occurring vasodilators synergistically interact on adenosine-induced vasodepression in rats: special reference to adrenomedullin. Fundam Clin Pharmacol. 1999;13:27-33.
28. Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol. 2002;29:312-316.
29. Malhotra J, Gupta YK. Effect of adenosine receptor modulation on pentylenetetrazole-induced seizures in rats. Br J Pharmacol. 1997;120:282-288.
30. Koh HC, Lee TK, Kang JS, et al. Modification of cardiovascular response of adenosine A2 receptor agonist by adenylate cyclase in the spinal cord of rats. Neurosci Lett. 2000;293:45-48.